Ironwood Pharmaceuticals (IRWD) Q4 2024 Annual Earnings
IRWD·Reported February 27, 2025·Before market open
Ironwood Pharmaceuticals reported Q4 2024 revenue of $90.5M, beat analyst consensus of $67.0M by $23.5M. Diluted EPS came in at $0.02, missed the $0.10 consensus by $0.08.
Revenue
$90.5Mbeat by $23.5M
Consensus: $67.0MDiluted EPS
$0.02missed by $0.08
Consensus: $0.10
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Ironwood Pharmaceuticals's Q4 2024 earnings report.
Ironwood Pharmaceuticals (IRWD) reported Q4 2024 earnings on February 27, 2025 before market open.
Ironwood Pharmaceuticals reported revenue of $90.5M and diluted EPS of $0.02 for Q4 2024.
Revenue beat the consensus estimate of $67.0M by $23.5M. EPS missed the consensus estimate of $0.10 by $0.08.
You can read the 10-K periodic report (0001558370-25-004072) directly on SEC EDGAR. The filing index links above go to sec.gov.